Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma

Janine Hensel; Antoinette Wetterwald; Ramzi Temanni; Irene Keller; Carsten Riether; Gabri van der Pluijm; Marco G. Cecchini; George N. Thalmann

doi:10.18632/oncotarget.25608

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma

Janine Hensel, Antoinette Wetterwald, Ramzi Temanni, Irene Keller, Carsten Riether, Gabri van der Pluijm, Marco G. Cecchini and George N. Thalmann _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:28877-28896. https://doi.org/10.18632/oncotarget.25608

Metrics: PDF 1536 views | HTML 2691 views | ?

Abstract

Janine Hensel1,2, Antoinette Wetterwald1,2, Ramzi Temanni3, Irene Keller4,5, Carsten Riether6,7, Gabri van der Pluijm8, Marco G. Cecchini1,2 and George N. Thalmann1,2

1Urology, Department for BioMedical Research, University of Bern, Bern, Switzerland

2Department of Urology, Inselspital, Bern University Hospital, Bern, Switzerland

3Biomedical Informatics Division, Research Branch, Sidra Medical and Research Center, Doha, Qatar

4Department for Biomedical Research, University of Bern, Bern, Switzerland

5Swiss Institute of Bioinformatics, University of Bern, Bern, Switzerland

6Tumor Immunology, Department for BioMedical Research, University of Bern, Bern, Switzerland

7Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland

8Department of Urology, Leiden University Medical Centre, Leiden, Netherlands

Correspondence to:

George N. Thalmann, email: [email protected]

Janine Hensel, email: [email protected]

Keywords: prostate and breast cancer; osteolytic bone metastasis; stroma; angiogenesis; axon guidance

Received: December 12, 2017 Accepted: May 02, 2018 Published: June 22, 2018

ABSTRACT

Prostate and breast cancers frequently metastasize to bone. The physiological bone homeostasis is perturbed once cancer cells proliferate at the bone metastatic site. Tumors are complex structures consisting of cancer cells and numerous stroma cells.

In this study, we show that osteolytic cancer cells (PC-3 and MDA-MB231) induce transcriptome changes in the bone/bone marrow microenvironment (stroma). This stroma transcriptome differs from the previously reported stroma transcriptome of osteoinductive cancer cells (VCaP). While the biological process “angiogenesis/vasculogenesis” is enriched in both transcriptomes, the “vascular/axon guidance” process is a unique process that characterizes the osteolytic stroma. In osteolytic bone metastasis, angiogenesis is denoted by vessel morphology and marker expression specific for arteries/arterioles. Interestingly, intra-tumoral neurite-like structures were in proximity to arteries. Additionally, we found that increased numbers of mesenchymal stem cells and vascular smooth muscle cells, expressing osteolytic cytokines and inhibitors of bone formation, contribute to the osteolytic bone phenotype.

Osteoinductive and osteolytic cancer cells induce different types of vessels, representing functionally different hematopoietic stem cell niches. This finding suggests different growth requirements of osteolytic and osteoinductive cancer cells and the need for a differential anti-angiogenic strategy to inhibit tumor growth in osteolytic and osteoblastic bone metastasis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25608

Publication Alerts

Research Papers:

Osteolytic cancer cells induce vascular/axon guidance processes in the bone/bone marrow stroma

Abstract